These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19342645)
1. Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction. Miller AT; Beisner DR; Liu D; Cooke MP J Immunol; 2009 Apr; 182(8):4696-704. PubMed ID: 19342645 [TBL] [Abstract][Full Text] [Related]
2. Inositol 1,4,5-trisphosphate 3-kinase B controls survival and prevents anergy in B cells. Maréchal Y; Quéant S; Polizzi S; Pouillon V; Schurmans S Immunobiology; 2011; 216(1-2):103-9. PubMed ID: 20452702 [TBL] [Abstract][Full Text] [Related]
3. Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells. Maréchal Y; Pesesse X; Jia Y; Pouillon V; Pérez-Morga D; Daniel J; Izui S; Cullen PJ; Leo O; Luo HR; Erneux C; Schurmans S Proc Natl Acad Sci U S A; 2007 Aug; 104(35):13978-83. PubMed ID: 17709751 [TBL] [Abstract][Full Text] [Related]
4. Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity. Wen BG; Pletcher MT; Warashina M; Choe SH; Ziaee N; Wiltshire T; Sauer K; Cooke MP Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5604-9. PubMed ID: 15064401 [TBL] [Abstract][Full Text] [Related]
5. Loss of the proapoptotic protein, Bim, breaks B cell anergy. Oliver PM; Vass T; Kappler J; Marrack P J Exp Med; 2006 Mar; 203(3):731-41. PubMed ID: 16520387 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune Disease. Miller AT; Dahlberg C; Sandberg ML; Wen BG; Beisner DR; Hoerter JA; Parker A; Schmedt C; Stinson M; Avis J; Cienfuegos C; McPate M; Tranter P; Gosling M; Groot-Kormelink PJ; Dawson J; Pan S; Tian SS; Seidel HM; Cooke MP PLoS One; 2015; 10(6):e0131071. PubMed ID: 26121493 [TBL] [Abstract][Full Text] [Related]
7. Inositol 1,4,5-trisphosphate 3-kinase B (Itpkb) controls survival, proliferation and cytokine production in mouse peripheral T cells. Pouillon V; Maréchal Y; Frippiat C; Erneux C; Schurmans S Adv Biol Regul; 2013 Jan; 53(1):39-50. PubMed ID: 22981169 [TBL] [Abstract][Full Text] [Related]
8. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology. Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760 [TBL] [Abstract][Full Text] [Related]
9. Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation. Miller AT; Sandberg M; Huang YH; Young M; Sutton S; Sauer K; Cooke MP Nat Immunol; 2007 May; 8(5):514-21. PubMed ID: 17417640 [TBL] [Abstract][Full Text] [Related]
10. Bim regulates B-cell receptor-mediated apoptosis in the presence of CD40 signaling in CD40-pre-activated splenic B cells differentiating into plasma cells. Gao Y; Kazama H; Yonehara S Int Immunol; 2012 May; 24(5):283-92. PubMed ID: 22301689 [TBL] [Abstract][Full Text] [Related]
11. Regulation of B cell survival, development and function by inositol 1,4,5-trisphosphate 3-kinase B (Itpkb). Schurmans S; Pouillon V; Maréchal Y Adv Enzyme Regul; 2011; 51(1):66-73. PubMed ID: 21035494 [TBL] [Abstract][Full Text] [Related]
12. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. Feuerstein N; Chen F; Madaio M; Maldonado M; Eisenberg RA J Immunol; 1999 Nov; 163(10):5287-97. PubMed ID: 10553051 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Mecklenbräuker I; Saijo K; Zheng NY; Leitges M; Tarakhovsky A Nature; 2002 Apr; 416(6883):860-5. PubMed ID: 11976686 [TBL] [Abstract][Full Text] [Related]
15. CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes. Li DH; Tung JW; Tarner IH; Snow AL; Yukinari T; Ngernmaneepothong R; Martinez OM; Parnes JR J Immunol; 2006 May; 176(9):5321-8. PubMed ID: 16621999 [TBL] [Abstract][Full Text] [Related]
16. Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival. Zikherman J; Doan K; Parameswaran R; Raschke W; Weiss A Proc Natl Acad Sci U S A; 2012 Jan; 109(1):E3-12. PubMed ID: 22135465 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival. Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813 [TBL] [Abstract][Full Text] [Related]
18. Modulation of peripheral B cell tolerance by CD72 in a murine model. Li DH; Winslow MM; Cao TM; Chen AH; Davis CR; Mellins ED; Utz PJ; Crabtree GR; Parnes JR Arthritis Rheum; 2008 Oct; 58(10):3192-204. PubMed ID: 18821699 [TBL] [Abstract][Full Text] [Related]